Baiju R. Shah is Chief Executive Officer of BioMotiv and co-leader of The Harrington Project for Discovery & Development. He has extensive experience in supporting the launch of early-stage biomedical companies. Prior to BioMotiv, Mr. Shah was President and CEO of BioEnterprise, a partnership of Case Western Reserve University, Cleveland Clinic, Summa Health System, and University Hospitals. BioEnterprise is a business formation, recruitment and acceleration initiative that directly assists client companies in securing resources and funding to support their growth, and also serves as a catalyst for major industry initiatives such as new capital sources, translational centers, and real estate projects. During Mr. Shah’s decade long tenure, the initiative assisted in the creation, recruitment, and acceleration of more than 110 bioscience companies in Cleveland that collectively attracted $1.3 Billion in new funding, primarily from venture capital and private equity sources. The initiative’s success has been recognized with several national awards and has helped establish the region as a recognized center of bioscience innovation.

Shah serves on the Board of Invacare (NYSE: IVC) and on an Advisory Board of Citizens Bank (NYSE: CFG). Prior to founding BioEnterprise, Shah was a consultant with McKinsey & Company, where he played a leading role in its Growth and Business Building practice. In the community, Shah serves on the Boards of Global Cleveland and Destination Cleveland. He was also the founder and Chair of TiE Ohio and Summer on the Cuyahoga.

Shah has been named an Ernst & Young Entrepreneur of the Year and has been recognized as one of Cleveland’s most influential leaders. He received a J.D. from Harvard Law School and a B.A. from Yale University.